November 10, 2017 / 2:55 PM / a month ago

BRIEF-Teligent announces FDA approval of betamethasone dipropionate ointment usp (augmented), 0.05%​

Nov 10 (Reuters) - Teligent Inc:

* Announces FDA approval of betamethasone dipropionate ointment USP (augmented), 0.05%​

* Expect to launch betamethasone dipropionate ointment USP (augmented), 0.05% in Q1 of 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below